Curry Colouring And Fat Mix Could Help Diabetics
Main Category: DiabetesAlso Included In: Clinical Trials / Drug Trials
Article Date: 15 Apr 2006 - 10:00 PST
| Patient / Public: | ![]() |
4 (8 votes) |
| Healthcare Prof: | ![]() |
3.5 (2 votes) |
Brisbane immunologist Dr Brendan O'Sullivan hopes to put a dent in skyrocketing rates of diabetes in Australia by creating a new treatment for Type 2 diabetes.
The Senior Research Officer and his team at UQ's Centre for Immunology and Cancer Research (CICR) are developing a drug that targets liver cells to prevent their inflammation in obesity -- a common precursor to diabetes.
Dr O'Sullivan has received a three-year $150,000 Smart State Fellowship from the State Government to explore potential diabetes treatments.
Arthritis Queensland and the CICR will also contribute a further $150,000 each during the project.
People with Type 2 diabetes cannot produce enough insulin or do not use the insulin they produce properly.
Insulin is a hormone produced by the pancreas which moves sugar from the food we eat into the body's cells.
Dr O'Sullivan said his technique involved coating treatment drugs in absorbable fat which formed an injectable dose that could last up to one week.
"One of the drugs we're using is curcumin, which is basically the yellow compound that you see in curries, which is an anti-inflammatory compound," Dr O'Sullivan said.
"The idea is to encapsulate that compound and then deliver it to the liver cells to prevent them from producing all these inflammatory compounds."
Early results show his method works in mice but he said his grant would validate the best method to use in human trials.
The 36-year-old from Kedron said that, if successful, the treatment could combat other diseases such as heart disease, osteoarthritis, rheumatoid arthritis and lupus, an autoimmune disease against the skin.
His Fellowship will pay for staff, lab and research work.
UQ's Deputy Vice-Chancellor (Research) Professor David Siddle said Dr O'Sullivan's project was one of many leading-edge CICR projects.
"Our determined immunologists are tackling some of society's worst diseases with great science," Professor Siddle said.
###
MEDIA: Dr O'Sullivan (+51 422 200 129) or Miguel Holland at UQ Communications (+61 733 652 619)
Contact: Miguel Holland
Research Australia
Visit our diabetes section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/41575.php>
APA
http://www.medicalnewstoday.com/releases/41575.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





